Intrinsic carnosine metabolism in the human kidney
Histidine-containing dipeptides like carnosine and anserine have protective functions in both health and disease. Animal studies suggest that carnosine can be metabolized within the kidney. The goal of this study was to obtain evidence of carnosine metabolism in the human kidney and to provide insig...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
24 July 2015
|
| In: |
Amino acids
Year: 2015, Volume: 47, Issue: 12, Pages: 2541-2550 |
| ISSN: | 1438-2199 |
| DOI: | 10.1007/s00726-015-2045-7 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00726-015-2045-7 Verlag, lizenzpflichtig, Volltext: https://link.springer.com/article/10.1007%2Fs00726-015-2045-7 
|
| Author Notes: | Verena Peters · Celine Q.F. Klessens · Hans J. Baelde · Benjamin Singler · Kimberley A.M. Veraar · Ana Zutinic · Jakub Drozak · Johannes Zschocke · Claus P. Schmitt · Emile de Heer |
| Summary: | Histidine-containing dipeptides like carnosine and anserine have protective functions in both health and disease. Animal studies suggest that carnosine can be metabolized within the kidney. The goal of this study was to obtain evidence of carnosine metabolism in the human kidney and to provide insight with regards to diabetic nephropathy. Expression, distribution, and localization of carnosinase-1 (CNDP1), carnosine synthase (CARNS), and taurine transporters (TauT) were measured in human kidneys. CNDP1 and CARNS activities were measured in vitro. CNDP1 and CARNS were located primarily in distal and proximal tubules, respectively. Specifically, CNDP1 levels were high in tubular cells and podocytes (20.3 ± 3.4 and 15 ± 3.2 ng/mg, respectively) and considerably lower in endothelial cells (0.5 ± 0.1 ng/mg). CNDP1 expression was correlated with the degradation of carnosine and anserine (r = 0.88 and 0.81, respectively). Anserine and carnosine were also detectable by HPLC in the renal cortex. Finally, TauT mRNA and protein were found in all renal epithelial cells. In diabetic patients, CNDP1 seemed to be reallocated to proximal tubules. We report compelling evidence that the kidney has an intrinsic capacity to metabolize carnosine. Both CNDP1 and CARNS are expressed in glomeruli and tubular cells. Carnosine-synthesizing and carnosine-hydrolyzing enzymes are localized in distinct compartments in the nephron and increased CNDP1 levels suggest a higher CNDP1 activity in diabetic kidneys. |
|---|---|
| Item Description: | Gesehen am 02.07.2020 |
| Physical Description: | Online Resource |
| ISSN: | 1438-2199 |
| DOI: | 10.1007/s00726-015-2045-7 |